MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

This multi-site, randomized, double-blind, confirmatory phase 3 study evaluated the efficacy and safety of 3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) versus placebo with identical therapy in participants with moderate to severe post-traumatic stress disorder (PTSD). Changes in Clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Jennifer M., Ot’alora G., Marcela, van der Kolk, Bessel, Shannon, Scott, Bogenschutz, Michael, Gelfand, Yevgeniy, Paleos, Casey, Nicholas, Christopher R., Quevedo, Sylvestre, Balliett, Brooke, Hamilton, Scott, Mithoefer, Michael, Kleiman, Sarah, Parker-Guilbert, Kelly, Tzarfaty, Keren, Harrison, Charlotte, de Boer, Alberdina, Doblin, Rick, Yazar-Klosinski, Berra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579091/
https://www.ncbi.nlm.nih.gov/pubmed/37709999
http://dx.doi.org/10.1038/s41591-023-02565-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579091/
https://www.ncbi.nlm.nih.gov/pubmed/37709999
http://dx.doi.org/10.1038/s41591-023-02565-4

Ejemplares similares